Comparison of potency assays to assess SARS-CoV-2 neutralizing antibody capacity in COVID-19 convalescent plasma

Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma

(2020) Chenguang Shen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Treatment with convalescent plasma for COVID-19 patients in Wuhan, China

(2020) Mingxiang Ye et al.   JOURNAL OF MEDICAL VIROLOGY

Virological assessment of hospitalized patients with COVID-2019

(2020) Roman Wölfel et al.   NATURE

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

(2020) Kai Duan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2

(2020) Yan Wu et al.   SCIENCE

A human monoclonal antibody blocking SARS-CoV-2 infection

(2020) Chunyan Wang et al.   Nature Communications

Evaluation of Serological Tests for SARS-CoV-2: Implications for Serology Testing in a Low-Prevalence Setting

(2020) Katherine Bond et al.   JOURNAL OF INFECTIOUS DISEASES

Validation and clinical evaluation of a SARS-CoV-2 Surrogate Virus Neutralisation Test (sVNT)

(2020) Benjamin Meyer et al.   Emerging Microbes & Infections

Collaborative networks enable the rapid establishment of serological assays for SARS-CoV-2 during nationwide lockdown in New Zealand

(2020) Reuben McGregor et al.   PeerJ

A simple protein-based surrogate neutralization assay for SARS-CoV-2

(2020) Kento T. Abe et al.   JCI Insight

Establishment of an Alphavirus-Specific Neutralization Assay to Distinguish Infections with Different Members of the Semliki Forest complex

(2019) Lisa Henss et al.   Viruses-Basel

Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience

(2018) Jae-Hoon Ko et al.   ANTIVIRAL THERAPY

The use of convalescent plasma to treat emerging infectious diseases

(2015) Anne M. Winkler et al.   CURRENT OPINION IN HEMATOLOGY

Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63

(2009) I. Glowacka et al.   JOURNAL OF VIROLOGY

Plaque assay for human coronavirus NL63 using human colon carcinoma cells

(2008) Petra Herzog et al.   Virology Journal